Drawing for HYPERSPECTRAL INTELLIGENCE

USPTO serial 98867887

HYPERSPECTRAL INTELLIGENCE

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
AVENT, TEAGUE A
Law office
TMO LAW OFFICE 126

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HYPERSPECTRAL INTELLIGENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew L. Frisbee

Matthew L. Frisbee Leason Ellis LLPOne North Lexington Ave., Suite 1200White Plains, NY 10601United States

Goods and services

ClassDescriptionStatusFirst use
009Scientific, research, photographic, cinematographic, audiovisual, optical, weighing, measuring, detecting, testing, inspecting and life-saving apparatus and instruments, namely, computers, cameras, sensors, stereoscopes, spectral imaging sensors, hyperspectral imaging cameras, hyperspectral imaging sensors, spectral imaging detectors, hyperspectral imaging detectors; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable software for conducting medical imaging and testing; downloadable computer software relating to the medical field for conducting imaging and testing; downloadable software for providing real-time surgical and medical information; downloadable software for performing medical diagnosis; downloadable computer software for use in medical decision support systems for providing real time medical information; downloadable platform software for conducting medical imaging and testing; downloadable software for data and image capture; downloadable AI software for conducting imaging and testing in the medical field; downloadable AI software for medical image analysis; downloadable AI-powered hyperspectral imaging software and apparatus being computers, cameras and sensors for providing real-time surgical and medical information; imaging apparatus, namely, cameras; electronic imaging devices, namely, cameras; cameras; optical apparatus and instruments; software as a medical device (SaMD), downloadable; spectral imaging cameras; computer peripheral devices; stereoscopic apparatus, namely, stereoscopes; all the foregoing related to medical imaging and medical diagnosticsACTIVE—
010Surgical and medical apparatus and instruments, namely, surgical instruments and apparatus; medical imaging apparatus; medical imaging apparatus for realtime data-driven tissue characterisation in surgical patients; medical imaging apparatus for visualising and characterising tissue intraoperatively; medical intraoperative imaging system; diagnostic imaging apparatus for medical use; imaging and sensing apparatus for medical use; optical imaging apparatus for medical purposes; AI imaging apparatus for medical purposes; medical imaging apparatus for providing real-time surgical and medical information; endoscopy cameras for medical purposes; cameras and sensors used for monitoring patients and surroundings during medical procedures, namely, medical imaging apparatus; optical diagnostic apparatus for medical purposes; endoscopy cameras for medical purposes; medical imaging apparatus for measuring oxygenation; spectral imaging cameras in the nature of medical imaging apparatus; detectors for medical applications, namely, sensors for medical use to gather human biometric dataACTIVE—
042Scientific and technological services, namely, computer software design and scientific research relating thereto; medical research services; design and development of computer hardware and software; software services, namely, providing temporary use of online, non-downloadable software for conducting medical imaging and testing, providing temporary use of online, non-downloadable AI software for medical image analysis; software services, namely, providing temporary use of online, non-downloadable AI-powered hyperspectral imaging software; design and development of software in the medical and surgical fields; development of computer software platforms; design and development of software for data and image capture; design and development of computer software for use with medical technology; providing temporary use of online, non-downloadable software for tracking and reporting on various medical matters; electronic data storage; cloud storage services for electronic data and files; research in the field of artificial intelligence technology; software as a service (SaaS) services featuring software for conducting medical imaging and testing; scientific information, advisory and consultancy services relating to the aforesaid; all the foregoing related to medical imaging and medical diagnosticsACTIVE—
044advanced computer assistance analysis for medical purposes, namely, providing computer-assisted surgical decision support during surgical procedures; hyperspectral medical imaging services in surgical patients; hyperspectral medical imaging services for carrying diagnostic information about tissue properties for objective tissue characterisation in surgical patients; providing real-time surgical and medical information, namely, medical advice; Medical services; medical imaging services; optical imaging services for medical diagnostic use; preparation of reports in the nature of medical consulting relating to medical matters; provision of reports being medical information relating to the medical examination of individuals; medical health assessment services; intraoperative health assessment services; medical diagnostic services; medical information; medical analysis services for the assessment of tissue health; medical analysis for the diagnosis and treatment of persons; monitoring of patients, namely, health assessment services; medical information, advisory and consultancy services relating to the aforesaidACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 10, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 10, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 10, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 9, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Mar 9, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Dec 10, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 12, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 12, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Nov 12, 2025CNSLSUSPENSION LETTER WRITTEN—
Oct 28, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 28, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 28, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 29, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 17, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 15, 2025DOCKASSIGNED TO EXAMINER—
Apr 26, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 22, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance